ASAlexandria L. Shaw

Alexandria L. Shaw

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandria L. Shaw has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of hydrogen deuterium exchange mass spectrometry in tandem with modern structural biology

    by Hunter G. Nyvall, Alexandria L. Shaw, Emma E. Walsh, Hirsh Bhatti, John E. Burke

    Hydrogen–deuterium exchange mass spectrometry (HDX-MS) is an established technique that measures the exchange rate of amide hydrogens, with this exchange rate being a surrogate for protein conformational dynamics. Advances in instrumentation, automation, and data analysis have transformed HDX-MS into a high-throughput and highly reproducible method capable of probing complex biological systems and addressing key questions that have been challenging to study by other structural biology approaches. By enabling measurement of amide exchange rates and mapping of differential exchange between distinct conformational states, HDX-MS provides insight into both allosteric transitions and protein interaction interfaces. Recent advances in the capabilities of artificial intelligence (AI) have been rapidly adopted by structural biology, leading to an unprecedented expansion in the quantity and accessibility of structural predictions, underscoring the need for experimental methods to validate these predicted models and provide insight into both epitopes and allosteric conformational changes. This is particularly critical for non-evolutionarily driven interactions such as antibodies, nanobodies, and artificially designed proteins, where AI technologies can yield false positives. This review highlights how HDX-MS can be integrated synergistically into modern structural biology workflows (cryo-EM, X-ray crystallography, and AI-enabled modeling) and how combining these approaches can be powerful to advance our mechanistic understanding of complex biological processes.


  • Open Access

    Phosphorylation of the C-terminus of PI4KA inhibits lipid kinase activity

    by Alexandria L Shaw, Sophia Doerr, Hunter G Nyvall, Meredith L Jenkins, Sushant Suresh, Calvin K Yip, Scott D Hansen, John E Burke

    Phosphatidylinositol 4-kinase alpha (PI4KA) is a lipid kinase that generates phosphatidylinositol 4-phosphate (PI4P) from phosphatidylinositol (PI) at the plasma membrane (PM). PI4P generated by PI4KA is essential for both plasma membrane identity and for PIP 2 and PIP 3 signalling driven by the PLC and PI3K family of enzymes. While the structure of PI4KA is known, the regulatory mechanisms that control its activity are undefined. Here, we discovered that PI4KA lipid kinase activity can be inhibited through tyrosine phosphorylation of the kα12 helix of the kinase domain (Y2090). This site can be phosphorylated by multiple tyrosine kinases. Structural studies using cryo-EM and HDX-MS defined the mechanism of how Y2090 phosphorylation inhibits activity, with this being driven through local conformational changes in the kα12 C-terminal helix of the PI4KA kinase domain. PI4KA activity is predominantly controlled through membrane recruitment by EFR3, with phosphorylation inhibiting the EFR3 tethered PI4KA complex. Phosphorylation of the kα12 C-terminal helix is found in multiple PI3Ks and PI4Ks, suggesting this may be an evolutionarily conserved regulatory mechanism for this family of phosphoinositide kinases. Overall, our work reveals novel molecular insight into inhibitory post-translational regulation of PI4KA.

  • Open Access

    Development of an inhibitory TTC7B selective nanobody that blocks EFR3 recruitment of PI4KA

    by Sushant Suresh, Alexandria L. Shaw, Damilola K. Akintola, Martine Lunke, Sophia Doerr, Pooja Rohilla, Tamas Balla, Calvin K. Yip, Scott D. Hansen, Jennifer A. Cobb, et al.


  • Open Access

    Biochemical and structural characterization of Rab3GAP reveals insights into Rab18 nucleotide exchange activity

    by Gage M. J. Fairlie, Kha M. Nguyen, Sung-Eun Nam, Alexandria L. Shaw, Matthew A. H. Parson, Hannah R. Shariati, Xinyin Wang, Meredith L. Jenkins, Michael Gong, John E. Burke, et al.

    The heterodimeric Rab3GAP complex is a guanine nucleotide exchange factor (GEF) for the Rab18 GTPase that regulates lipid droplet metabolism, ER-to-Golgi trafficking, secretion, and autophagy. Why both subunits of Rab3GAP are required for Rab18 GEF activity and the molecular basis of how Rab3GAP engages and activates its cognate substrate are unknown. Here we show that human Rab3GAP is conformationally flexible and potentially autoinhibited by the C-terminal domain of its Rab3GAP2 subunit. Our high-resolution structure of the catalytic core of Rab3GAP, determined by cryo-EM, shows that the Rab3GAP2 N-terminal domain binds Rab3GAP1 via an extensive interface. AlphaFold3 modelling analysis together with targeted mutagenesis and in vitro activity assay reveal that Rab3GAP likely engages its substrate Rab18 through an interface away from the switch and interswitch regions. Lastly, we find that three Warburg Micro Syndrome-associated missense mutations do not affect the overall architecture of Rab3GAP but instead likely interfere with substrate binding.


  • Open Access

    Molecular basis for plasma membrane recruitment of PI4KA by EFR3

    by Sushant Suresh, Alexandria L. Shaw, Joshua G. Pemberton, Mackenzie K. Scott, Noah J. Harris, Matthew A. H. Parson, Meredith L. Jenkins, Pooja Rohilla, Alejandro Alvarez-Prats, Tamas Balla, et al.

    The lipid kinase phosphatidylinositol 4 kinase III α (PI4KIIIα/PI4KA) is a master regulator of the lipid composition and asymmetry of the plasma membrane. PI4KA exists primarily in a heterotrimeric complex with its regulatory proteins TTC7 and FAM126. Fundamental to PI4KA activity is its targeted recruitment to the plasma membrane by the lipidated proteins EFR3A and EFR3B. Here, we report a cryogenic electron microscopy structure of the C terminus of EFR3A bound to the PI4KA-TTC7B-FAM126A complex, with extensive validation using both hydrogen deuterium exchange mass spectrometry, and mutational analysis. The EFR3A C terminus undergoes a disorder-order transition upon binding to the PI4KA complex, with an unexpected direct interaction with both TTC7B and FAM126A. Complex disrupting mutations in TTC7B, FAM126A, and EFR3 decrease PI4KA recruitment to the plasma membrane. Multiple posttranslational modifications and disease linked mutations map to this site, providing insight into how PI4KA membrane recruitment can be regulated and disrupted in human disease.


  • Open Access

    Structure of Calcineurin bound to PI4KA reveals dual interface in both PI4KA and FAM126A

    by Alexandria L Shaw, Sushant Suresh, Matthew Ah Parson, Noah J Harris, Meredith L Jenkins, Calvin K Yip, John E Burke

    Phosphatidylinositol 4-kinase alpha (PI4KA) maintains the PI4P and phosphatidylserine pools of the plasma membrane. A key regulator of PI4KA is its association into a complex with TTC7 and FAM126 proteins. This complex can be regulated by the CNAβ1 isoform of the phosphatase Calcineurin. We previously identified that CNAβ1 directly binds to FAM126A. Here, we report a cryo-EM structure of a truncated PI4KA complex bound to Calcineurin, revealing a direct Calcineurin interaction with PI4KA. Additional HDX-MS and computational analysis show that Calcineurin forms a complex with an evolutionarily conserved IKISVT sequence in PI4KA’s horn domain. We also characterised conserved LTLT and PSISIT Calcineurin binding sequences in the C-terminus of FAM126A. These sites are in close proximity to phosphorylation sites in the PI4KA complex, suggesting key roles of Calcineurin-regulated phosphosites in PI4KA regulation. This work reveals novel insight into how Calcineurin can regulate PI4KA activity.

  • Open Access

    Molecular basis for the recruitment of the Rab effector protein WDR44 by the GTPase Rab11

    by Matthew C. Thibodeau, Noah J. Harris, Meredith L. Jenkins, Matthew A.H. Parson, John T. Evans, Mackenzie K. Scott, Alexandria L. Shaw, Daniel Pokorný, Thomas A. Leonard, John E. Burke